Literature DB >> 24026889

[Infection and sepsis prevention in prostate biopsy].

F M E Wagenlehner1, A Pilatz, P Waliszewski, T Dansranjavin, W Weidner.   

Abstract

Prostate biopsy is currently the gold standard in the diagnosis of carcinoma of the prostate. An estimated one million prostate biopsies are performed every year in Europe. Worldwide the most frequent form is the transrectal prostate biopsy using preoperative fluoroquinolone prophylaxis. In recent years an increasing rate of infectious complications after prostate biopsy has been observed. The main causative factor is fecal fluoroquinolone-resistant bacteria. This review aims to present the current evidence regarding infectious complications after prostate biopsy and strategies to reduce symptomatic infections and urosepsis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24026889     DOI: 10.1007/s00120-013-3284-4

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  26 in total

1.  Fluoroquinolone-resistant E. coli in intestinal flora of patients undergoing transrectal ultrasound-guided prostate biopsy--should we reassess our practices for antibiotic prophylaxis?

Authors:  D Steensels; K Slabbaert; L De Wever; P Vermeersch; H Van Poppel; J Verhaegen
Journal:  Clin Microbiol Infect       Date:  2011-09-29       Impact factor: 8.067

2.  Single-dose antibiotic prophylaxis in core prostate biopsy: Impact of timing and identification of risk factors.

Authors:  Sandra Lindstedt; Ulla Lindström; Eva Ljunggren; Björn Wullt; Magnus Grabe
Journal:  Eur Urol       Date:  2006-05-16       Impact factor: 20.096

3.  Bacterial sepsis following prostatic biopsy.

Authors:  Luca Carmignani; Stefano Picozzi; Matteo Spinelli; Salvatore Di Pierro; Gabriella Mombelli; Ercole Negri; Milvana Tejada; Paola Gaia; Elena Costa; Augusto Maggioni
Journal:  Int Urol Nephrol       Date:  2012-02-28       Impact factor: 2.370

Review 4.  Antibiotic prophylaxis for transrectal prostate biopsy.

Authors:  Emerson L Zani; Otavio Augusto Camara Clark; Nelson Rodrigues Netto
Journal:  Cochrane Database Syst Rev       Date:  2011-05-11

5.  Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care.

Authors:  Aisha K Taylor; Teresa R Zembower; Robert B Nadler; Marc H Scheetz; John P Cashy; Diana Bowen; Adam B Murphy; Elodi Dielubanza; Anthony J Schaeffer
Journal:  J Urol       Date:  2012-02-16       Impact factor: 7.450

6.  Influence of a prophylactic single dose of ciprofloxacin on the level of resistance of Escherichia coli to fluoroquinolones in urology.

Authors:  F Wagenlehner; J Stöwer-Hoffmann; W Schneider-Brachert; K G Naber; N Lehn
Journal:  Int J Antimicrob Agents       Date:  2000-08       Impact factor: 5.283

Review 7.  Preoperative assessment of the patient and risk factors for infectious complications and tentative classification of surgical field contamination of urological procedures.

Authors:  Magnus Grabe; Henry Botto; Mete Cek; Peter Tenke; Florian M E Wagenlehner; Kurt G Naber; Truls E Bjerklund Johansen
Journal:  World J Urol       Date:  2011-07-22       Impact factor: 4.226

8.  Uncomplicated urinary tract infections.

Authors:  Florian M E Wagenlehner; Udo Hoyme; Martin Kaase; Reinhard Fünfstück; Kurt G Naber; Guido Schmiemann
Journal:  Dtsch Arztebl Int       Date:  2011-06-17       Impact factor: 5.594

9.  Concentrations of cefpodoxime in plasma, ejaculate and in prostatic fluid and adenoma tissue.

Authors:  K G Naber; M Kinzig; D Adam; F Sörgel; A H Bajorski; R Kiehn
Journal:  Infection       Date:  1991 Jan-Feb       Impact factor: 3.553

10.  Concentrations of trimethoprim and sulphamethoxazole in the human prostate gland after intramuscular injection.

Authors:  W L Wright; P Larking; C J Lovell-Smith
Journal:  Br J Urol       Date:  1982-10
View more
  1 in total

1.  Prognostic Value of Adrenomedullin and Natriuretic Peptides in Uroseptic Patients Induced by Ureteroscopy.

Authors:  Wei Hu; Pang-Hu Zhou; Wei Wang; Lijun Zhang; Xiao-Bin Zhang
Journal:  Mediators Inflamm       Date:  2016-01-05       Impact factor: 4.711

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.